Corey Giasson, President and CEO of MustGrow Biologics (CSE: MGRO)(OTC: MGROF) joins Cory Fleck of the Korelin Economics Report to introduce the Company’s strategy to bring the technology to commercialization. Click the link below to listen to the full interview.
MustGrow Biologics – Ag-Biotech Company Moving Toward Commercialization Of Its Technology
